It is usually marketed and formulated as a steady, cosmetic-use peptide for long-term texture support
Excessive Alcohol: Alcohol can irritate the stomach lining and increase the risk of low blood sugar
Successful PCP-led GLP-1 management requires baseline documentation of weight, blood pressure, lipids, and kidney function
It is also consistent with a small clinical trial study of the GLP-1RA drug exenatide, which significantly reduced heavy drinking days and total alcohol intake in patients with obesity 12 and with a register-based study in Demark showing that GLP-1RAs (though semaglutide was not included) compared with dipeptidyl peptidase 4 inhibitors (DPP4) were associated with lower incidence of alcohol-related events in 20092017 13
After completing detox, ongoing treatment and support are essential for maintaining long-term recovery and preventing relapse
While clinical trials show significant average weight loss with FDA-approved GLP-1 medications, results are not guaranteed and compounded formulations have not been evaluated in the same clinical trial framework